This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Marfl Ab. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Santanu Dasgupta: Innovator in Immunology and Medicine
Introduction
Santanu Dasgupta is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the fields of immunology and medicine through his innovative research and inventions. His work focuses on the genes and proteins involved in the sporulation of Mycobacteria, which are crucial for developing treatments for diseases such as leprosy and tuberculosis.
Latest Patents
Santanu Dasgupta holds 1 patent related to his research. The patent describes an invention that involves a vaccine comprising spore-forming peptides, such as CotA or CotD, or antibodies targeting these peptides. This vaccine is designed for the treatment of diseases caused by Mycobacteria, showcasing his commitment to advancing medical science.
Career Highlights
Currently, Santanu Dasgupta is associated with Marfl AB, where he continues to work on innovative solutions in the medical field. His expertise and dedication have positioned him as a valuable asset in the research community.
Collaborations
Some of his notable coworkers include Leif Kirsebom and Pontus Larsson. Their collaborative efforts contribute to the advancement of research and development in their respective fields.
Conclusion
Santanu Dasgupta's work exemplifies the impact of innovation in addressing critical health challenges. His contributions to immunology and medicine are paving the way for future advancements in disease treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile